Literature DB >> 15961271

Cognitive impairment in three subtypes of multiple sclerosis.

Douglas R Denney1, Lisa A Sworowski, Sharon G Lynch.   

Abstract

Patients with relapsing, primary progressive, and secondary progressive MS were administered the Tower of London and the Stroop Color-Word Interference Test, yielding several measures of executive function and speeded information processing. MS patients' performance was compared with healthy controls and with a clinical control group consisting of patients with rheumatoid arthritis. The MS patients performed the tests more slowly, but did not differ from either group of controls on measures of executive function. Slowing in the speed of information processing was characteristic of MS patients across two basic tasks differing in terms of controlled versus automatic processing and in terms of whether or not rapid responding was an explicit feature of successful performance. Although evident in all subtypes, this slowing was more pronounced in secondary progressive patients and somewhat less pronounced in primary progressive patients. Furthermore, the slowing was unrelated to patients' disability status or level of depression.

Entities:  

Mesh:

Year:  2005        PMID: 15961271     DOI: 10.1016/j.acn.2005.04.012

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  23 in total

1.  Enhanced GABAergic Tonic Inhibition Reduces Intrinsic Excitability of Hippocampal CA1 Pyramidal Cells in Experimental Autoimmune Encephalomyelitis.

Authors:  Laura G Kammel; Weizheng Wei; Shekib A Jami; Rhonda R Voskuhl; Thomas J O'Dell
Journal:  Neuroscience       Date:  2018-11-14       Impact factor: 3.590

2.  Validity of the Italian multiple sclerosis neuropsychological screening questionnaire.

Authors:  Simone Migliore; Doriana Landi; Francesca Proietti; Giulia D'Aurizio; Ferdinando Squitieri; Giorgia Mataluni; Carolina Gabri Nicoletti; Giuseppe Curcio; Girolama Alessandra Marfia
Journal:  Neurol Sci       Date:  2021-03-02       Impact factor: 3.307

3.  Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus.

Authors:  B Cesar; M G Dwyer; J L Shucard; P Polak; N Bergsland; R H B Benedict; B Weinstock-Guttman; D W Shucard; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2015-06-11       Impact factor: 3.825

4.  Self-efficacy as a longitudinal predictor of perceived cognitive impairment in individuals with multiple sclerosis.

Authors:  Abbey J Hughes; Meghan Beier; Narineh Hartoonian; Aaron P Turner; Dagmar Amtmann; Dawn M Ehde
Journal:  Arch Phys Med Rehabil       Date:  2015-01-15       Impact factor: 3.966

5.  Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis.

Authors:  R S Prakash; E M Snook; J M Lewis; R W Motl; A F Kramer
Journal:  Mult Scler       Date:  2008-08-13       Impact factor: 6.312

6.  The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.

Authors:  Jelena Dackovic; Tatjana Pekmezovic; Sarlota Mesaros; Irena Dujmovic; Nebojsa Stojsavljevic; Vanja Martinovic; Jelena Drulovic
Journal:  Neurol Sci       Date:  2016-05-20       Impact factor: 3.307

7.  Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.

Authors:  Simone Migliore; Anna Ghazaryan; Ilaria Simonelli; Patrizio Pasqualetti; Doriana Landi; Maria Giuseppina Palmieri; Filomena Moffa; Pasquale Rinaldi; Fabrizio Vernieri; Maria Maddalena Filippi
Journal:  Neurol Sci       Date:  2016-04-20       Impact factor: 3.307

Review 8.  Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option?

Authors:  Christopher Christodoulou; William S MacAllister; Nancy A McLinskey; Lauren B Krupp
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  Gulf War illness (GWI) as a neuroimmune disease.

Authors:  Apostolos P Georgopoulos; Lisa M James; Adam F Carpenter; Brian E Engdahl; Arthur C Leuthold; Scott M Lewis
Journal:  Exp Brain Res       Date:  2017-07-31       Impact factor: 1.972

Review 10.  Treatment and management of cognitive dysfunction in patients with multiple sclerosis.

Authors:  John DeLuca; Nancy D Chiaravalloti; Brian M Sandroff
Journal:  Nat Rev Neurol       Date:  2020-05-05       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.